MicroRNA expression patterns in adrenocortical carcinoma variants and clinical pathologic correlations

Human Pathology

Volumn 45, Issue 8, 2014, Pages 1555-1562

  Duregon, Eleonora ^a   Rapa, Ida ^a   Votta, Arianna ^a   Giorcelli, Jessica ^a   Daffara, Fulvia ^a   Terzolo, Massimo ^a   Scagliotti, Giorgio V ^a   Volante, Marco ^a   Papotti, Mauro ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Adrenal cortex; Carcinoma; microRNA; Prognosis; Variant

Indexed keywords

ADRENAL CORTEX; CARCINOMA; MICRORNA; PROGNOSIS; VARIANT;

ADRENAL CORTEX NEOPLASMS; ADRENOCORTICAL CARCINOMA; ADULT; AGED; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; YOUNG ADULT;

EID: 84904705630     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2014.04.005     Document Type: Article

References (38)

1. A. Berruti, E. Baudin, and H. Gelderblom et al. Adrenal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up Ann Oncol 23 2012 131 138
2. M. Papotti, R. Libe, E. Duregon, M. Volante, J. Bertherat, and F. Tissier The Weiss score and beyond - histopathology for adrenocortical carcinoma Horm Cancer 2 2011 333 340
3. L.M. Weiss Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors Am J Surg Pathol 8 1984 163 169
4. L.M. Weiss, L.J. Medeiros, and A.L. Vickery Jr. Pathologic features of prognostic significance in adrenocortical carcinoma Am J Surg Pathol 13 1989 202 206
5. F. Tissier, S. Aubert, and E. Leteurtre et al. Adrenocortical tumors: improving the practice of the Weiss system through virtual microscopy: a National Program of the French Network INCa-COMETE Am J Surg Pathol 36 2012 1194 1201
6. E. Duregon, A. Fassina, and M. Volante et al. The reticulin algorithm for adrenocortical tumor diagnosis: a multicentric validation study on 245 unpublished cases Am J Surg Pathol 37 2013 1433 1440
7. A.M. McNicol A diagnostic approach to adrenal cortical lesions Endocr Pathol 19 2008 241 251
8. M. Papotti, M. Volante, and E. Duregon et al. Adrenocortical tumors with myxoid features: a distinct morphologic and phenotypical variant exhibiting malignant behavior Am J Surg Pathol 34 2010 973 983
9. M. Bisceglia, O. Ludovico, and A. Di Mattia et al. Adrenocortical oncocytic tumors: report of 10 cases and review of the literature Int J Surg Pathol 12 2004 231 243
10. E. Duregon, M. Volante, and S. Cappia et al. Oncocytic adrenocortical tumors: diagnostic algorithm and mitochondrial DNA profile in 27 cases Am J Surg Pathol 35 2011 1882 1893
11. A. Weissferdt, A. Phan, S. Suster, and C.A. Moran Myxoid adrenocortical carcinoma: a clinicopathologic and immunohistochemical study of 7 cases, including 1 case with lipomatous metaplasia Am J Clin Pathol 139 2013 780 786
12. J. Zhang, J. Sun, Z. Liang, J. Gao, X. Zeng, and T. Liu Myxoid adrenocortical neoplasms: a study of the clinicopathologic features and EGFR gene status of ten Chinese cases Am J Clin Pathol 136 2011 783 792
13. E. Duregon, M. Volante, J. Giorcelli, M. Terzolo, E. Lalli, and M. Papotti Diagnostic and prognostic role of steroidogenic factor 1 in adrenocortical carcinoma: a validation study focusing on clinical and pathologic correlates Hum Pathol 44 2013 822 828
14. T.M. Rana Illuminating the silence: understanding the structure and function of small RNAs Nat Rev Mol Cell Biol 8 2007 23 36
15. P.S. Soon, L.J. Tacon, and A.J. Gill et al. miR-195 and miR-483-5p identified as predictors of poor prognosis in adrenocortical cancer Clin Cancer Res 15 2009 7684 7692
16. M. Doghman, A. El Wakil, and B. Cardinaud et al. Regulation of insulin-like growth factor-mammalian target of rapamycin signaling by microRNA in childhood adrenocortical tumors Cancer Res 70 2010 4666 4675
17. E.E. Patterson, A.K. Holloway, J. Weng, T. Fojo, and E. Kebebew MicroRNA profiling of adrenocortical tumors reveals miR-483 as a marker of malignancy Cancer 117 2011 1630 1639
18. D.M. Ozata, S. Caramuta, and D. Velazquez-Fernandez et al. The role of microRNA deregulation in the pathogenesis of adrenocortical carcinoma Endocr Relat Cancer 18 2011 643 655
19. O. Chabre, R. Libe, and G. Assie et al. Serum miR-483-5p and miR-195 are predictive of recurrence risk in adrenocortical cancer patients Endocr Relat Cancer 20 2013 579 594
20. D. Patel, M. Boufraqech, and M. Jain et al. miR-34a and miR-483-5p are candidate serum biomarkers for adrenocortical tumors Surgery 154 2013 1224 1228
21. Z. Tombol, P.M. Szabo, and V. Molnar et al. Integrative molecular bioinformatics study of human adrenocortical tumors: microRNA, tissue-specific target prediction, and pathway analysis Endocr Relat Cancer 16 2009 895 906
22. S. Bandiera, S. Ruberg, and M. Girard et al. Nuclear outsourcing of RNA interference components to human mitochondria PLoS One 6 2011 e20746
23. M. Volante, E. Bollito, and P. Sperone et al. Clinicopathological study of a series of 92 adrenocortical carcinomas: from a proposal of simplified diagnostic algorithm to prognostic stratification Histopathology 55 2009 535 543
24. E. Duregon, L. Molinaro, and M. Volante et al. Comparative diagnostic and prognostic performances of the hematoxylin-eosin and phospho-histone H3 mitotic count and Ki-67 index in adrenocortical carcinoma Mod Pathol 2014 10.1038/modpathol.2013.230 [E-pub Jan 17]
25. M.W. Pfaffl A new mathematical model for relative quantification on real-time RT-PCR Nucleic Acids Res 29 2001 e45
26. A. Veronese, L. Lupini, and J. Consiglio et al. Oncogenic role of miR-483-3p at the IGF2/483 locus Cancer Res 70 2010 3140 3149
27. D.D. Wong, D.V. Spagnolo, M. Bisceglia, M. Havlat, D. McCallum, and M.A. Platten Oncocytic adrenocortical neoplasms: a clinicopathologic study of 13 new cases emphasizing the importance of their recognition Hum Pathol 42 2011 489 499
28. T. Bertero, I. Bourget-Ponzio, and A. Puissant et al. Tumor suppressor function of miR-483-3p on squamous cell carcinomas due to its pro-apoptotic properties Cell Cycle 12 2013 2183 2193
29. A.M. Porcelli, A. Ghelli, and C. Ceccarelli et al. The genetic and metabolic signature of oncocytic transformation implicates HIF1alpha destabilization Hum Mol Genet 19 2010 1019 1032
30. C. Gicquel, X. Bertagna, and V. Gaston et al. Molecular markers and long-term recurrences in a large cohort of patients with sporadic adrenocortical tumors Cancer Res 61 2001 6762 6767
31. P.S. Soon, R. Libe, and D.E. Benn et al. Loss of heterozygosity of 17p13, with possible involvement of ACADVL and ALOX15B, in the pathogenesis of adrenocortical tumors Ann Surg 247 2008 157 164
32. M.P. Vargas, H.I. Vargas, D.E. Kleiner, and M.J. Merino Adrenocortical neoplasms: role of prognostic markers MIB-1, P53, and RB Am J Surg Pathol 21 1997 556 562
33. S. Sbiera, S. Schmull, and G. Assie et al. High diagnostic and prognostic value of steroidogenic factor-1 expression in adrenal tumors J Clin Endocrinol Metab 95 2010 161 171
34. L. Hong, J. Yang, Y. Han, Q. Lu, J. Cao, and L. Syed High expression of miR-210 predicts poor survival in patients with breast cancer: a meta-analysis Gene 507 2012 135 138
35. T. Greither, L.F. Grochola, A. Udelnow, C. Lautenschlager, P. Wurl, and H. Taubert Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated with poorer survival Int J Cancer 126 2010 73 80
36. H.E. Gee, C. Camps, and F.M. Buffa et al. hsa-mir-210 is a marker of tumor hypoxia and a prognostic factor in head and neck cancer Cancer 116 2010 2148 2158
37. H. Cai, L. Lin, H. Cai, M. Tang, and Z. Wang Prognostic evaluation of microRNA-210 expression in pediatric osteosarcoma Med Oncol 30 2013 499
38. S. Qiu, S. Lin, D. Hu, Y. Feng, Y. Tan, and Y. Peng Interactions of miR-323/miR-326/miR-329 and miR-130a/miR-155/miR-210 as prognostic indicators for clinical outcome of glioblastoma patients J Transl Med 11 2013 10